Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar 4;70(2):e20230801.
doi: 10.1590/1806-9282.20230801. eCollection 2024.

Comparison of menstrual cycle irregularities among young women based on coronavirus disease 2019 infection status: a cross-sectional study

Affiliations

Comparison of menstrual cycle irregularities among young women based on coronavirus disease 2019 infection status: a cross-sectional study

Elif Doğan et al. Rev Assoc Med Bras (1992). .

Erratum in

  • Erratum.
    [No authors listed] [No authors listed] Rev Assoc Med Bras (1992). 2025 Mar 31;71(2):e20230801ERRATUM. doi: 10.1590/1806-9282.20230801ERRATUM. Rev Assoc Med Bras (1992). 2025. PMID: 40172406 Free PMC article.

Abstract

Objective: The coronavirus disease 2019 pandemic that has emerged recently has significantly affected and continues to affect our lives. The Severe Acute Respiratory Syndrome Coronavirus 2 virus has significant effects on women's health due to gender-related physiological differences. The aim of this study was to compare the menstrual cycle status of young women according to their status of having had coronavirus disease 2019.

Methods: This descriptive cross-sectional study was conducted with 220 young women aged between 18 and 25 years who received at least one dose of coronavirus disease 2019 vaccine. The study data were collected as a survey on the online platform.

Results: The descriptive characteristics of young women who had had and had not had coronavirus disease 2019 were distributed homogeneously between the groups (p>0.05). Furthermore, there was no statistical difference in terms of menstrual cycle patterns (p>0.05). The mean scores from the Premenstrual Syndrome Scale and its subscales and the mean scores from the COVID Stress Scale and its subscales were similar in both groups, and no statistically significant difference was identified (p>0.05).

Conclusion: Although menstrual cycle irregularities due to coronavirus disease 2019 have been reported, these effects are usually observed during the pandemic. A decrease in stress and anxiety with the end of the pandemic may explain the return of the menstrual cycle to normal.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: the authors declare there is no conflicts of interest.

Figures

Figure 1
Figure 1. Strengthening the Reporting of Observational Studies in Epidemiology flow diagram.

References

    1. Dabbousi AA, Masri J, Ayoubi LM, Ismail O, Zreika B, Salameh P. Menstrual abnormalities post-COVID vaccination: a cross-sectional study on adult Lebanese women. Ir J Med Sci. 2023;192((3)):1163–70. doi: 10.1007/s11845-022-03089-5. - DOI - PMC - PubMed
    1. Ceban F, Ling S, Lui LMW, Lee Y, Gill H, Teopiz KM, et al. Fatigue and cognitive impairment in post-COVID-19 syndrome: a systematic review and meta-analysis. Brain Behav Immun. 2022;101:93–35. doi: 10.1016/j.bbi.2021.12.020. - DOI - PMC - PubMed
    1. Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397((10270)):220–32. doi: 10.1016/S0140-6736(20)32656-8. - DOI - PMC - PubMed
    1. Rotshild V, Hirsh-Raccah B, Miskin I, Muszkat M, Matok I. Comparing the clinical efficacy of COVID-19 vaccines: a systematic review and network meta-analysis. Sci Rep. 2021;11((1)):22777. doi: 10.1038/s41598-021-02321-z. - DOI - PMC - PubMed
    1. Meo SA, Bukhari IA, Akram J, Meo AS, Klonoff DC. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and moderna vaccines. Eur Rev Med Pharmacol Sci. 2021;25((3)):1663–9. doi: 10.26355/eurrev_202102_24877. - DOI - PubMed

Substances